Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes
暂无分享,去创建一个
Ursula Schmidt-Erfurth | Horst Laqua | S. Michels | U. Schmidt-Erfurth | G. Naumann | U. Schlötzer-Schrehardt | A. Viestenz | S. Michels | H. Laqua | Ursula Schlötzer-Schrehardt | Gottfried O. Naumann | Arne Viestenz
[1] V. Fingar,et al. Vascular effects of photodynamic therapy. , 1996, Journal of clinical laser medicine & surgery.
[2] A. Moor,et al. Signaling pathways in cell death and survival after photodynamic therapy. , 2000, Journal of photochemistry and photobiology. B, Biology.
[3] P. Campochiaro,et al. VEGF is major stimulator in model of choroidal neovascularization. , 2000, Investigative ophthalmology & visual science.
[4] J A Cardillo,et al. Choriocapillaris photodynamic therapy using indocyanine green. , 2001, American journal of ophthalmology.
[5] W. Heriot,et al. Pigment epithelial repair , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.
[6] Joan W. Miller,et al. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization. , 1996, Archives of ophthalmology.
[7] G A Peyman,et al. Problems with and pitfalls of photodynamic therapy. , 2000, Ophthalmology.
[8] T. Dougherty,et al. HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.
[9] Joan W. Miller. Photodynamic Therapy for Choroidal Neovascularization , 2019 .
[10] P. Wiedemann,et al. Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy , 2001, The British journal of ophthalmology.
[11] T J Flotte,et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. , 1995, Archives of ophthalmology.
[12] Joan W. Miller,et al. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys. , 1996, Ophthalmology.
[13] U. Schmidt-Erfurth,et al. Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. , 2000, Survey of ophthalmology.
[14] R Birngruber,et al. Vascular targeting in photodynamic occlusion of subretinal vessels. , 1994, Ophthalmology.
[15] J. Duker,et al. The photodynamic occlusion of choroidal vessels using benzoporphyrin derivative. , 1994, Current eye research.
[17] N. Bressler,et al. Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples , 1998, Graefe's Archive for Clinical and Experimental Ophthalmology.
[18] P. Kaiser. Photodynamic therapy with verteporfin for choroidal neovascularization , 2000 .
[19] U. Schmidt-Erfurth,et al. Histopathological changes following photodynamic therapy in human eyes. , 2002, Archives of ophthalmology.
[20] H. Laqua,et al. Photodynamische Therapie Empfehlungen für Indikation und Behandlung , 2001, Der Ophthalmologe.
[21] R Birngruber,et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. , 1999, Archives of ophthalmology.